Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb 22;15(1):1619.
doi: 10.1038/s41467-024-45355-3.

Concordance of randomised controlled trials for artificial intelligence interventions with the CONSORT-AI reporting guidelines

Affiliations

Concordance of randomised controlled trials for artificial intelligence interventions with the CONSORT-AI reporting guidelines

Alexander P L Martindale et al. Nat Commun. .

Erratum in

Abstract

The Consolidated Standards of Reporting Trials extension for Artificial Intelligence interventions (CONSORT-AI) was published in September 2020. Since its publication, several randomised controlled trials (RCTs) of AI interventions have been published but their completeness and transparency of reporting is unknown. This systematic review assesses the completeness of reporting of AI RCTs following publication of CONSORT-AI and provides a comprehensive summary of RCTs published in recent years. 65 RCTs were identified, mostly conducted in China (37%) and USA (18%). Median concordance with CONSORT-AI reporting was 90% (IQR 77-94%), although only 10 RCTs explicitly reported its use. Several items were consistently under-reported, including algorithm version, accessibility of the AI intervention or code, and references to a study protocol. Only 3 of 52 included journals explicitly endorsed or mandated CONSORT-AI. Despite a generally high concordance amongst recent AI RCTs, some AI-specific considerations remain systematically poorly reported. Further encouragement of CONSORT-AI adoption by journals and funders may enable more complete adoption of the full CONSORT-AI guidelines.

PubMed Disclaimer

Conflict of interest statement

Several authors (X.L., D.M., A.D., C.K., L.F.R., C.L., A.W.C., M.C., P.K., G.S.C., R.G., L.O.R., M.M., C.Y., S.C.R., A.B.) were involved in the development of CONSORT-AI. MC receives funding from the NIHR, UK Research and Innovation (UKRI), NIHR BRC, the NIHR Surgical Reconstruction and Microbiology Research Centre, NIHR ARC West Midlands, NIHR Birmingham-Oxford Blood and Transplant Research Unit (BTRU) in Precision Transplant and Cellular Therapeutics, UKSPINE, European Regional Development Fund – Demand Hub and Health Data Research UK at the University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, Innovate UK (part of UKRI), Macmillan Cancer Support, UCB Pharma, GSK and Gilead. M.C. has received personal fees from Astellas, Aparito Ltd, CIS Oncology, Takeda, Merck, Daiichi Sankyo, Glaukos, GSK and the Patient-Centred Outcomes Research Institute (PCORI) outside the submitted work. X.L. and A.D. have received funding from the NHS AI Lab, The Health Foundation, NIHR, NIHR BRC, MHRA and NICE, outside the submitted work. A.D. and M.C. are supported by the NIHR Birmingham Biomedical Research Centre. The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. C.K. is an employee of Google, UK. L.F.R. is an employee of York Health Economics Consortium (YHEC). The remaining authors declare no competing interests.

Figures

Fig. 1
Fig. 1
PRISMA flow diagram.
Fig. 2
Fig. 2. Location heatmap of included studies by country, showing high distribution within China and USA.
Generated using R Statistical Software (v4.1.1, R Core Team 2021).
Fig. 3
Fig. 3
Distribution of clinical specialties amongst included RCTs, showing a high prevalence of interventions within gastroenterology.

Similar articles

Cited by

References

    1. Tyler, N. S. et al. An artificial intelligence decision support system for the management of type 1 diabetes. Nat. Metab.2, 612–619 (2020). - PMC - PubMed
    1. McKinney, S. M. et al. International evaluation of an AI system for breast cancer screening. Nature577, 89–94 (2020). - PubMed
    1. Beaulieu-Jones, B. K. et al. Machine learning for patient risk stratification: standing on, or looking over, the shoulders of clinicians? npj Digit. Med.4, 1–6 (2021). - PMC - PubMed
    1. Liu, X. et al. A comparison of deep learning performance against health-care professionals in detecting diseases from medical imaging: a systematic review and meta-analysis. Lancet Digit. Health1, e271–e297 (2019). - PubMed
    1. Strohm, L., Hehakaya, C., Ranschaert, E. R., Boon, W. P. C. & Moors, E. H. M. Implementation of artificial intelligence (AI) applications in radiology: hindering and facilitating factors. Eur. Radio.30, 5525–5532 (2020). - PMC - PubMed

Publication types